You are here: AU  Staff Departments  iNANO News and events News Show

NNF, Tandem Programme

2018.01.09 | Yvonne Eskildsen-Helmond

The Novo Nordisk Foundation - Tandem Programme-Translational Research Collaboration between Basic and Clinical Researchers

Deadline: January 9, 2018

&nbs

PURPOSE

With the Tandem Programme the Novo Nordisk Foundation wishes to stimulate a collaboration between one clinical and one basic research leader to stimulate the transition of basic research to clinical practice and vice versa.

ELIGIBILITY

The applicant and project must be anchored at a university, hospital or other non-profit research institution in Denmark. Only applications where a basic and a clinical researcher establish a cross-disciplinary collaboration are eligible for funding.

Beside the main applicant, the application must include one co-applicant who will receive a defined part of the grant as detailed in the application, and it must be clear from the application how the project collaboration is ensured and distributed. Both researchers should be tenured, as the Tandem Programme will not cover the salary for the applicant or co-applicant. The main applicant can be either the basic researcher or the clinical researcher.

RESEARCH FIELD

Patient and disease related research, clinical and translational medical research, disease mechanisms, treatment methods, disease trajectories, diagnostic methods, public health, epidemiology, clinical trials and clinical testing etc. The Committee for Clinical and Translational Medical Research supports research that involves patients/humans and/or clinical practice, diagnostic or therapeutic methods, and it is essential, that the project is within this scope.

FUNDING

A total of DKK 15 million are available for the funding of a 4-year programme grant for a clearly defined collaborative research project.

Four Tandem Programmes of up to DKK 15 million per programme can be granted in 2017.

Read more here

Funding opportunities
Tags: Novo Nordisk, Biomedical Research
4871 / i35